|
|
Volumn 14, Issue SUPPL. 2, 2000, Pages 14-19
|
|
European hepatitis B immunoglobulin trials: Prevention of recurrent hepatitis B after liver transplantation
|
|
Author keywords
Antibody; HBlg; HBsAg; Hepatitis B; Liver; Transplantation
|
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
VIRUS DNA;
ARTICLE;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MEGADOSE;
EUROPE;
GRAFT FAILURE;
HEPATITIS B;
HUMAN;
INFECTION RISK;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RECURRENCE RISK;
RECURRENT DISEASE;
COST CONTROL;
DNA, VIRAL;
EUROPE;
GRAFT SURVIVAL;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
INJECTIONS, INTRAMUSCULAR;
INJECTIONS, INTRAVENOUS;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
RECURRENCE;
TIME FACTORS;
|
|
EID: 0033858688
PISSN: 09020063
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-0012.2000.140104.x Document Type: Article |
|
Times cited : (19)
|
|
References (9)
|
